Keyphrases
RNA Vaccine Platform
100%
Circular RNA
100%
Chikungunya Virus (CHIKV)
100%
Vaccination
100%
Efficacy Study
62%
Viremia
62%
Immunogenicity
50%
University of Texas
50%
Cynomolgus Macaque
37%
Positive Control
37%
Necropsy
37%
Temperature Logger
37%
Animal Efficacy
37%
Bleeding
37%
Neutralizing Antibodies
37%
Vaccine Candidate
25%
Large Mammals
25%
Rodent Models
25%
IgG Antibody
25%
Fever
25%
Footpad
25%
IgM Antibody
25%
Small Rodents
25%
Pathological Lesions
25%
CHIKV Infection
25%
Experimental Vaccines
25%
Clinical Scoring
25%
Small Animal
25%
BSL-4
25%
Rebudgeting
12%
Purchase Price
12%
Lab Safety
12%
Detailed List
12%
AG129 Mice
12%
Neutralizing Titer
12%
Clinical Survival
12%
Minor Surgical Procedures
12%
Vaccine Dose
12%
Plaque-forming Units
12%
Novel Vaccines
12%
Weight Loss
12%
Nonhuman Primate Model
12%
Plaque Reduction Neutralization
12%
Academic Research
12%
Houston
12%
Sham
12%
Safety Study
12%
One Dose
12%
Blood Collection
12%
GLP Study
12%
Antibody Binding
12%
Methodist
12%
Day 14
12%
Animal Sera
12%
Historic Data
12%
Prime-boost Strategy
12%
Mouse Model
12%
Cytokine Response
12%
Lethal Dose
12%
Galveston
12%
Efficacy Data
12%
Clinical Disease
12%
Post-infection
12%
Weaver
12%
Body Temperature
12%
Biocontainment
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chikungunya
100%
RNA Vaccine
100%
Viremia
100%
Efficacy Study
100%
Infection
80%
Immunogenicity
80%
Macaca fascicularis
60%
Ciclonicate
60%
Cytokine
60%
Neutralizing Antibody
60%
Immunoglobulin G Antibody
20%
Immunoglobulin M Antibody
20%
Disease
20%
Mouse Model
20%
Vaccine
20%
Preclinical Study
20%
Biocontainment
20%
Immunoglobulin M
20%
Immunology and Microbiology
RNA Vaccine
100%
Viremia
100%
Immunogenicity
80%
Animal Experiment
60%
Neutralizing Antibody
60%
Macaca fascicularis
60%
Cytokine
40%
Vaccine Efficacy
20%
Immunoglobulin M Antibody
20%
Immunoglobulin G Antibody
20%
Preclinical Study
20%
Titer
20%
Blood Sampling
20%
Cytokine Response
20%
Antibody Titer
20%
Body Temperature
20%
Binding Antibody
20%
Plaque-Forming Unit
20%
Mouse Model
20%
Neutralization
20%
Immunoglobulin M
20%
Vaccine
20%